03:20 AM EST, 11/29/2024 (MT Newswires) -- David Alan Campbell, Director, President and Chief Executive Officer, on November 25, 2024, sold 25,000 shares in Janux Therapeutics ( JANX ) for $1,289,879. Following the Form 4 filing with the SEC, Campbell has control over a total of 257,054 shares of the company, with 257,054 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1817713/000141588924027905/xslF345X05/form4-11272024_081102.xml